• LAST PRICE
    2.4300
  • TODAY'S CHANGE (%)
    Trending Down-0.0900 (-3.5714%)
  • Bid / Lots
    2.4200/ 1
  • Ask / Lots
    2.4900/ 22
  • Open / Previous Close
    2.5100 / 2.5200
  • Day Range
    Low 2.4000
    High 2.5500
  • 52 Week Range
    Low 1.7700
    High 7.4000
  • Volume
    144,709
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 2.52
TimeVolumeSLS
09:32 ET28442.51
09:35 ET12492.51
09:39 ET3002.525
09:42 ET86582.52
09:44 ET2002.529
09:46 ET5002.5006
09:48 ET1002.5184
09:51 ET1002.467
09:55 ET20002.49
10:00 ET10002.49
10:04 ET8002.5034
10:06 ET2502.51
10:08 ET2502.4726
10:15 ET3452.49
10:20 ET121122.45
10:22 ET45732.46
10:26 ET50002.4928
10:27 ET57042.4934
10:29 ET25242.54
10:42 ET12002.5
10:45 ET31002.52
10:49 ET122142.4901
11:03 ET4002.5
11:16 ET30002.45
11:20 ET23142.4434
11:21 ET1902.425
11:23 ET5002.45
11:32 ET1002.44
11:38 ET3502.44
12:01 ET5002.4385
12:06 ET9512.43
12:14 ET7062.42
12:15 ET1002.42
12:21 ET19002.42
12:26 ET11002.424
12:28 ET19002.4108
12:35 ET10002.43
12:39 ET3002.424
12:42 ET54002.45
12:55 ET49222.48
12:57 ET10002.4377
01:11 ET29002.4699
01:24 ET10002.46
01:27 ET5502.4523
01:45 ET2002.4262
01:49 ET5002.44
01:54 ET7002.42
01:56 ET6842.4
02:00 ET195702.49
02:03 ET1002.47
02:07 ET10172.46
02:14 ET10002.48
02:23 ET2002.48
02:30 ET8002.47
02:34 ET3002.46
02:48 ET50002.4699
02:50 ET1002.4438
02:56 ET1002.47
03:19 ET4292.44
03:24 ET10002.4386
03:28 ET18002.42
03:30 ET14002.4202
03:32 ET25002.425
03:42 ET3002.425
03:44 ET3252.425
03:57 ET13252.43
04:00 ET4882.43
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSLS
Sellas Life Sciences Group Inc
51.9M
-1.1x
---
United StatesOCX
OncoCyte Corp
57.0M
-0.7x
---
United StatesAVTX
Avalo Therapeutics Inc
51.9M
-1.0x
---
United StatesAWH
Aspira Women's Health Inc
45.1M
-1.3x
---
United StatesTCRX
TScan Therapeutics Inc
53.2M
-0.8x
---
United StatesADAG
Adagene Inc
47.3M
-0.6x
---
As of 2022-12-06

Company Information

SELLAS Life Sciences Group, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing cancer immunotherapeutics for a range of cancer indications. The Company's product candidates include galinpepimut-S (GPS) and nelipepimut-S (NPS). Its lead product candidate, GPS, is a cancer immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center (MSK) that targets the Wilms tumor 1 (WT1) protein, which is present in 20 or more cancer types. GPS has potential both as a monotherapy and in combination to address a range of hematologic malignancies and solid tumor indications. Its second product candidate, NPS, is a cancer immunotherapy targeting the human epidermal growth factor receptor 2 (HER2), which is expressing cancers with potential for the treatment of patients with early-stage breast cancer with low to intermediate HER2 expression, which includes triple negative breast cancer (TNBC) patients.

Contact Information

Headquarters
7 TIMES SQUARE, SUITE 2503NEW YORK, NY, United States 10036
Phone
646-200-5278
Fax
925-498-7799

Executives

Independent Chairman of the Board
Jane Wasman
President, Chief Executive Officer, Director
Angelos Stergiou
Executive Vice President, General Counsel, Corporate Secretary
Barbara Wood
Chief Accounting Officer, Vice President - Finance, Corporate Controller
John Burns
Senior Vice President - Clinical Development
Dragan Cicic

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$51.9M
Revenue (TTM)
$1.0M
Shares Outstanding
20.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.11
EPS
$-2.22
Book Value
$1.28
P/E Ratio
-1.1x
Price/Sales (TTM)
51.9
Price/Cash Flow (TTM)
---
Operating Margin
-4,412.30%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.